# A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

> **NCT07541261** · — · NOT_YET_RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 100 (estimated)

## Conditions studied

- Colitis
- Ulcerative
- Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07541261
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-17
- **Primary completion:** 2029-01-02
- **Final completion:** 2029-01-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07541261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07541261, "A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07541261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*